This presentation will cover updates in CPPD disease epidemiology, classification criteria, and long-term outcomes in the joint and beyond the joint. Thanks to our sponsor Johnson & Johnson Innovative Medicine.
Speaker Bio:
Dr. Sara Tedeschi is a rheumatologist and clinical investigator at Brigham and Women’s Hospital, where she is Head of Crystalline Arthritic Diseases. She is Principal Investigator of the NIH-funded CRYSTALLIZE trial of colchicine versus placebo in CPPD disease. She co-led the development of the ACR/EULAR CPPD Disease Classification Criteria and serves as Co-Chair of the OMERACT CPPD Working Group. Dr. Tedeschi also serves on the American College of Rheumatology Quality of Care Criteria Subcommittee.
Who Should Attend:
Rheumatologists, fellows, residents, allied health professionals, and others interested in advancing rheumatology practice and patient care.
Dinner will be provided, and CME and ACPE credits will be available.
If you are registering as an MSL or TLL, register as an Affiliate Member or Non-Member.
CME and ACPE credits are available after the dinner, watch your email for a link to download your Quarterly Dinner CE certificate. Stay tuned for the accreditation language.
Parking
Citron has 240 car spots. All free parking.
.png)